HE4 overexpression promotes chemoresistance in ovarian cancer cells

被引：0
|
作者：
Singh, R. [1 ]
Horan, T. [1 ]
Yano, N. [1 ]
Kim, K. [1 ]
Lange, T. [1 ]
Lambert-Messerlian, G. [1 ]
Moore, R. [1 ]
机构：
[1] Brown Univ, Women & Infants Hosp, Providence, RI USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
331
引用
收藏
页码：S136 / S136
页数：1
相关论文
共 50 条
  • [1] HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
    J. R. Ribeiro
    C. Schorl
    N. Yano
    N. Romano
    K. K. Kim
    R. K. Singh
    R. G. Moore
    Journal of Ovarian Research, 9
  • [2] HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
    Ribeiro, J. R.
    Schorl, C.
    Yano, N.
    Romano, N.
    Kim, K. K.
    Singh, R. K.
    Moore, R. G.
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [3] HE4 (WFDC2) gene overexpression promotes ovarian tumor growth
    Richard G. Moore
    Emily K. Hill
    Timothy Horan
    Naohiro Yano
    KyuKwang Kim
    Shannon MacLaughlan
    Geralyn Lambert-Messerlian
    YiTang Don Tseng
    James F. Padbury
    M. Craig Miller
    Thilo S. Lange
    Rakesh K. Singh
    Scientific Reports, 4
  • [4] HE4 (WFDC2) gene overexpression promotes ovarian tumor growth
    Moore, Richard G.
    Hill, Emily K.
    Horan, Timothy
    Yano, Naohiro
    Kim, KyuKwang
    MacLaughlan, Shannon
    Lambert-Messerlian, Geralyn
    Tseng, YiTang Don
    Padbury, James F.
    Miller, M. Craig
    Lange, Thilo S.
    Singh, Rakesh K.
    SCIENTIFIC REPORTS, 2014, 4
  • [5] EVALUATION OF HE4 IN OVARIAN CANCER
    Nakajima, T.
    Nagaishi, M.
    Maebayashi, A.
    Miyakawa, Y.
    Ikeda, Y.
    Sato, M.
    Kawana, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 785 - 785
  • [6] HE4 - A novel biomarker for ovarian cancer
    Verch, Thorsten
    Glover, Curtis L.
    Beyer, Heather L.
    Tran, Ly
    Geschwindt, Ryan D.
    Hellstrom, Ingegerd
    Hellstrom, Karl-Erik
    Sardesai, Niranjan Y.
    Allard, W. Jeffrey
    TUMOR BIOLOGY, 2007, 28 : 108 - 108
  • [7] HE4 and other markers in ovarian cancer
    Kucera, R.
    Topolcan, O.
    Svobodova, S.
    Presl, J.
    Fuchsova, R.
    Vrzalova, J.
    Rokyta, Z.
    Betincova, L.
    Novotny, Z.
    17TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2013, : 173 - 175
  • [8] Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer
    Zhu, Liancheng
    Zhuang, Huiyu
    Wang, Huimin
    Tan, Mingzi
    Schwab, Carlton L.
    Deng, Lu
    Gao, Jian
    Hao, Yingying
    Li, Xiao
    Gao, Song
    Liu, Juanjuan
    Lin, Bei
    ONCOTARGET, 2016, 7 (01) : 729 - 744
  • [9] HE4: really a novel biomarker for ovarian cancer?
    Yucel, E.
    Ilter, E.
    Aksungar, F. B.
    Celik, A.
    Peker, B. H.
    Serifsoy, E.
    Bozkurt, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (01) : 59 - 64
  • [10] Diagnostic and Prognostic Potential of HE4 in Ovarian Cancer
    Langhe, R.
    O'Toole, S.
    Norris, L.
    Petzold, M.
    Harrison, A.
    Varley, R.
    Abusaadeh, F.
    Gleeson, N.
    O'Leary, J.
    MODERN PATHOLOGY, 2013, 26 : 284A - 284A
12345